Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the antibiotic Zithromax (azithromycin), Viagra (sildenafil) for erectile dysfunction, and the anti-inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside the USA and Canada, mainly in South America).
Pfizer profit falls on hit from generic Lipitor
May 01 - France24
Nestlé pays top price for Pfizer baby meals arm
Apr 23 - Independent
Nestle wins pricey battle for Pfizer baby food unit
Apr 23 - Financial Post
Nestlé may have deal to buy Pfizer baby milk
Apr 18 - Independent
Antitrust disposals on horizon for Nestlé
Apr 18 - Financial Times
Pfizer 'nears' $9 bn deal with Nestle
Apr 18 - France24
‘No dearth of interest for biosimilar insulin’
Mar 13 - The Times of India
Pfizer scraps $350m deal with Biocon
Mar 13 - The Times of India
Danone, Nestle Said to Plan Strategies for Pfizer Infant Unit
Feb 17 - Business Week
Danone, Nestle Said to Plan Bid Strategies for Pfizer Unit
Feb 17 - Business Week
Drugmaker Rebates Would Rise $156 Billion in Obama Budget
Feb 13 - Business Week
Pfizer Recalls 1 Million Birth-Control Packs on Wrong Dosage
Feb 11 - Business Week
Pfizer to hive off animal health biz
Feb 07 - The Times of India
Pfizer Beats Estimates on Cost Cuts and Non-Drug Revenue
Feb 02 - Business Week
Supreme court denies Pfizer bid to block production of generic eye drug
Feb 02 - Financial Post
Pfizer recalls birth control pills in US
Feb 01 - France24
Pfizer Recalls 1 Million Birth-Control Packs on Wrong Dosage
Feb 01 - Business Week
Pfizer profit skids on Lipitor loss
Jan 31 - France24
Pfizer misses Street view, warns on stronger dollar
Jan 31 - Financial Post
Glaxo, Lilly, Pfizer Said to Be Interested in Turkey’s MN Pharma
Jan 31 - Business Week
By Reuters
A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare neurodegenerative disease. The U.S. Food and Drug Administration panel voted 13 to 4 that the drug did not show that it met the main goal in a study in treating the fatal condition. (May 25)
MORE TOPICS: NEW YORK
By IBTimes
Portuguese investment bank Espirito Santo has downgraded Indian bio-technology major Biocon from "neutral" to "sell" based on several issues, including accounting practices which the bank says are objectionable. (May 22)
MORE TOPICS: INVESTMENT, SETTLEMENT
By Reuters
Experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to U.S. approval, under a proposal likely to become law this year. U.S. (May 09)
By Ausfoodnews
One of the world's largest food and nutrition companies, Nestlé, has announced its intention to acquire US-based global nutrition company Pfizer Nutrition for US$11.85 billion (AU$11.5 billion). (May 04)
MORE TOPICS: GOLD, MANUFACTURING, EMERGING MARKETS
By Reuters
Biotech companies are fighting back in an unequal battle with Big Pharma, helped by a small but powerful cohort of investors who dominate the companies' share registers. (May 02)
MORE TOPICS: CARL ICAHN, COMMERZBANK, GOLDMAN SACHS, NEW YORK, MANAGEMENT, GLAXOSMITHKLINE
By IBTimes
The companies whose shares are moving in pre-market trade Wednesday are: Protalix BioTherapeutics, Charming Shoppes, Tripadvisor, Genworth Financial, Wynn Resorts, UBS AG, Herbalife, CBS Corp, Patni Computer Systems and Chesapeake Energy Corp. (May 02)
By Aireview
The Reserve Bank dominates the coming week in Australia. But the April jobs report and a host of other data is out in the US will keep us interested. (May 01)
MORE TOPICS: CHINA, GOLD, AIG, WESTPAC, MANUFACTURING, AUSTRALIA
By Reuters
U.S. stocks advanced on Tuesday, with the Nasdaq gaining 1 percent, after data showed the manufacturing sector expanded in April, easing jitters about a slowdown in the economic recovery. (May 01)
MORE TOPICS: CHINA, DOW JONES, MORGAN STANLEY, GERMANY, MANUFACTURING, MEXICO
By Reuters
Pfizer Inc <PFE.N> reported higher-than-expected quarterly earnings as improved profit margins and strong sales of its Lyrica nerve-pain drug partly offset plunging demand for its Lipitor cholesterol fighter, now facing cheaper generic rivals. (May 01)
By Reuters
Stock index futures edged higher on Tuesday ahead of data on the manufacturing sector that could offer evidence on the pace of the economic recovery. (May 01)
MORE TOPICS: CHINA, DOW JONES, FTSE, GERMANY, MANUFACTURING, MEXICO
Free Edition
TAKE A TOURStay connected with the IBTimes using your favorite social networks and online news applications:
We value your privacy. Your email address will not be shared.
